Abstract
Thermoablative techniques currently represent, in accordance with international guidelines, the most used methods in the treatment of varicose veins. From some years, lasers with a wavelength greater than 1900 nm have been introduced for EndoVenous Laser Ablation (EVLA) treatment. However, currently, few clinical studies regarding this new technology are reported in the medical literature. The aim of this study is to evaluate outcomes at a 2-year follow-up (mid-term) of EVLA of varicose veins of the lower limbs using a 1940-nm laser and a new cylindric monoring fiber. This clinical trial was conducted as a multicenter, retrospective, non-randomized, non-blind clinical study. Ninety-three patients were enrolled for a total of one hundred consecutive procedures performed in the period between January 2021 and May 2021 in two Italian facilities. The primary efficacy endpoint was the occlusion rate of the treated vein immediately after surgery and at the follow-up (24 months). The secondary efficacy endpoint was the evaluation of the parameters of energy delivered during the procedure (power and linear energy density or LEED). The primary safety endpoints were the incidence of pain (1 day and 7 days after surgery) and the rate of intraoperative and postoperative complications. The precepted pain was evaluated with the visual analog scale (VAS). The secondary safety endpoint was the evaluation of the improvement of the patient’s symptoms related to venous disease. This evaluation was conducted by recording the changes in clinical, etiologic, anatomic, and pathophysiologic (CEAP) classification. All procedures were carried out regularly on an outpatient basis, and no intraoperative complications occurred. The occlusion rate of the target veins was 100% at 7- and 30-day controls. At follow-up controls, performed at 6 months, 1 and 2 years carried out showed an occlusion rate respectively of 99% (97 to 100), 96.9% (93.6 to 100), and 95.9% (92.1 to 99.9). The secondary efficacy endpoint was the evaluation of the parameters of energy delivered during the procedure (power watt and linear energy density): As regards the power parameters, we report an average of watts of 4.5 ± 0.8 [2.5 to 6] and linear energy density delivered (LEED) of 41.2 ± 8.6 [(21.1 to 66.7)]. The pain reported (with VAS scale) on 1 day of the procedure was 2 [1; 3] and 1 [0 to 4] at 7 days. All patients showed improved symptoms related to venous disease, with reduction of the individual CEAP class to which they belong. This study demonstrates that EndoVascular Laser Ablation (EVLA) treatment of varicose veins with a wavelength > 1900 nm is safe and effective. The overall occlusion rate was high. The reported results suggest that using lower parameters, such as output power (watts) and LEED (linear energy density), do not reduce the success rate of the treatment when used over 35 J/cm.
Similar content being viewed by others
References
Andreozzi GM, Cordova R, Scomparin MA, Martini R, D’Eri A, Andreozzi F et al (2005) Quality of life in chronic venous insufficiency: an Italian pilot study of the Triveneto region. Int Angiol 24:272–277
Carradice D, Mazari FAK, Samuel N, Allgar V, Hatfield J, Chetter IC (2011) Modelling the effect of venous disease on quality of life. Br J Surg 98:1089–1098
Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML et al (2011) The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 53(5 Suppl):2S-48S. https://doi.org/10.1016/j.jvs.2011.01.079
Wittens C, Davies AH, Bækgaard N, Broholm R, Cavezzi A, Chastanet S et al (2015) Editor’s Choice - Management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 49(6):678–737
De Maeseneer, European Society for Vascular Surgery (ESVS) et al (2022) Clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg S1078–5884(21)00979–5. https://doi.org/10.1016/j.ejvs.2021.12.024
Quarto G, Amato B, Giani U, Benassai G, Gallinoro E, Apperti M, Furino E (2016) Comparison of traditional surgery and laser treatment of incontinent great saphenous vein. Results of a meta-analysis. Ann Ital Chir 87(1):61–67
Park I, Park SC (2020) Comparison of short-term outcomes between endovenous 1,940-nm laser ablation and radiofrequency ablation for incompetent saphenous veins. Front Surg 11(7):620034. https://doi.org/10.3389/fsurg.2020.620034
Horecker BL (1943) The absorption spectra of hemoglobin and its derivatives in the visible and near infra-red regions. J Biol Chem 148:173–183
Kuenstner JT, Norris KH (1994) Spectrophotometry of human hemoglobin in the near infrared region from 1000 to 2500 nm. J Near Infrared Spetrosc 2:59–65
Bosschaart N, Edelman G, Aalders MCG, van Leeuwen TG, Faber DJ (2013) A literature review and novel theoretical approach on the optical properties of whole blood. Lasers Med Sci. https://doi.org/10.1007/s10103-013-1446-7
Setia A, Schmedt CG, Beisswenger A, Dikic S, Demhasaj S, Setia O, Schmitz-Rixen T, Sroka R (2022) Safety and efficacy of endovenous laser ablation (EVLA) using 1940 nm and radial emitting fiber: 3-year results of a prospective, non-randomized study and comparison with 1470 nm. Lasers Surg Med 54(4):511–522. https://doi.org/10.1002/lsm.23500
Fabián V, Honěk J, Horváth V, Horváth M, Šlais M, Vítovec M, Stehno O, Šedivý P, Šebesta P, Weiss J, Honěk T (2022) Endovenous laser ablation of saphenous veins - favorable clinical results confirm theoretical advantages of the 1940nm diode laser. Rozhl Chir Fall 101(8):395–400. https://doi.org/10.33699/PIS.2022.101.8.395-400 (English)
Bianchi PG, Martinelli F, Quarto G, Palombi L (2022) The evolution of endovenous laser ablation (EVLA). A single-center experience with a 1470 nm versus a 1940 nm diode laser. Ann Ital Chir 93:578–583
Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A (2006) Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs – UIP consensus document. Part I. Basic principles. Eur J Vasc Endovasc Surg 31(1):83–92
Cavezzi A, Labropoulos N, Partsch H et al (2006) Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs – UIP consensus document. Part II. Anatomy Eur J Vasc Endovasc Surg 31(3):288–99
Robertson L, Evans C, Fowkes FG (2008) Epidemiology of chronic venous disease. Phlebology 23(3):103–111. https://doi.org/10.1258/phleb.2007.007061
NICE Guidance. www.nice.org.uk/guidance/cg168. Varicose veins: diagnosis and management. Clinical guideline [CG168] Published date: July 2013
Teter KA, Kabnick LS, Sadek M (2020) Endovenous laser ablation: a comprehensive review. Phlebology 35(9):656–662. https://doi.org/10.1177/0268355520937619
Paravastu SC, Horne M, Dodd PD (2016) Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins. Cochrane Database Syst Rev 11(11):CD010878. https://doi.org/10.1002/14651858.CD010878.pub2
Niemz MH (2007) Biological and medical physics, biomedical enginnering - laser-tissue interactions, fundamentals and applications. 3rd. New York: Springer Berlin Heidelberg. [Google Scholar]. https://link.springer.com/book/10.1007/978-3-540-72192-5
Cowpland CA, Cleese AL, Whiteley MS (2017) Factors affecting optimal linear endovenous energy density for endovenous laser ablation in incompetent lower limb truncal veins - a review of the clinical evidence. Phlebology 32:299–306
Malskat WSJ, Engels LK, Hollestein LM, Nijsten T, van den Bos RR (2019) Commonly used endovenous laser ablation (EVLA) Parameters do not influence efficacy: results of a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 58(2):230–242. https://doi.org/10.1016/j.ejvs.2018.10.036
Artemov SA et al (2021) Morphological changes of veins and perivenous tissues during endovenous laser coagulation using 2-μm laser radiation and various types of optical fibers. J Vasc Surg Venous Lymphat Disord S2213–333X(21)00428–5. https://doi.org/10.1016/j.jvsv.2021.08.018
Whiteley MS (2019) If it looks like a duck, swims like a duck, and quacks like a duck, then it probably is a duck. What “the duck test” tells us about systematic reviews and meta-analyses of LEED and other EVLA parameters. Eur J Vasc Endovasc Surg 58(2):243. https://doi.org/10.1016/j.ejvs.2019.04.023
Vuylsteke M, Liekens K, Moons P, Mordon S (2008) Endovenous laser treatment of saphenous vein reflux: how much energy do we need to prevent recanalizations? Vasc Endovascular Surg 42:141e9
Setia A, Schmedt CG, Sroka R (2022) Endovenous laser ablation using laser systems emitting at wavelengths > 1900 nm: a systematic review. Lasers Med Sci 37(9):3473–3483. https://doi.org/10.1007/s10103-022-03609-w
Setia A, Schmedt CG, Beisswenger A, Dikic S, Demhasaj S, Setia O, Schmitz-Rixen T, Sroka R (2022) Safety and efficacy of endovenous laser ablation (EVLA) using 1940 nm and radial emit- ting fiber: 3-year results of a prospective, non-randomized study and comparison with 1470 nm. Lasers Surg Med 54(4):511–522. https://doi.org/10.1002/lsm.23500
Viarengo LMA, Viarengo G, Martins AM, Mancini MW, Lopes LA (2017) Resultados de médio e longo prazo do tratamento endovenoso de varizes com laser de diodo em 1940 nm: análise crítica e considerações técnicas. J Vasc Bras 16(1):23–30
Ashpitel HF, Dabbs EB, Nemchand JL, La Ragione RM, Salguero FJ, Whiteley MS (2018) Histological and immunofluorescent analysis of a large tributary of the great saphenous vein treated with a 1920 nm endovenous laser: preliminary findings. EJVES Short Rep 18(39):7–11. https://doi.org/10.1016/j.ejvssr.2018.03.003
Whiteley MS, Cross AC, Whiteley VC (2022) No significant difference between 1940 and 1470 nm in endovenous laser ablation using an in vitro porcine liver model. Lasers Med Sci. 37(3):1899–1906. https://doi.org/10.1007/s10103-021-03449-0
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
Conception and design: LP; analysis and interpretation: DB, LP, and GQ; data collection: LP, MM, FM, and PGB; writing the article: LP and MM; critical revision of the article: GQ; final approval of the article: all authors; overall responsibility: LP.
Corresponding author
Ethics declarations
Competing interests
L. Palombi provides consultive advice to NeoLaser L.t.d., Caesarea, Israel. All other authors state “no conflict of interest.”
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Palombi, L., Morelli, M., Bruzzese, D. et al. Endovenous laser ablation (EVLA) for vein insufficiency: two-year results of a multicenter experience with 1940-nm laser diode and a novel optical fiber. Lasers Med Sci 39, 61 (2024). https://doi.org/10.1007/s10103-024-04000-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10103-024-04000-7